![Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses | npj Vaccines Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses | npj Vaccines](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41541-020-00243-x/MediaObjects/41541_2020_243_Fig2_HTML.png)
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses | npj Vaccines
![Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic](https://www.frontiersin.org/files/Articles/566882/fphar-11-00937-HTML/image_m/fphar-11-00937-g004.jpg)
Frontiers | A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
![Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses | npj Vaccines Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses | npj Vaccines](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41541-020-00243-x/MediaObjects/41541_2020_243_Fig1_HTML.png)
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses | npj Vaccines
![Vaccines | Free Full-Text | COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform Vaccines | Free Full-Text | COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform](https://pub.mdpi-res.com/vaccines/vaccines-09-00171/article_deploy/html/images/vaccines-09-00171-ag.png?1614563915)
Vaccines | Free Full-Text | COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform
![AdventHealth begins recruiting participants for Phase 3 COVID-19 Investigational vaccine clinical trial | AdventHealth Research Institute AdventHealth begins recruiting participants for Phase 3 COVID-19 Investigational vaccine clinical trial | AdventHealth Research Institute](https://www.adventhealthresearchinstitute.com/sites/default/files/styles/crop_2_1/public/2020-11/GettyImages-1209679031_1.jpg?itok=xLetjBZf)
AdventHealth begins recruiting participants for Phase 3 COVID-19 Investigational vaccine clinical trial | AdventHealth Research Institute
Vaccines and Related Biological Products Advisory Committee February 26, 2021 Meeting Briefing Document- Sponsor
P00081 Modification to MCDC OTA No. W150KN-16-9-1002 BETWEEN JANSSEN PHARMACEUTICALS, INC. 1125 TRENTON-HARBOURTON ROAD TITUSVIL
![Latest COVID-19 vaccine based on technology tested for safety & immunogenicity in IMI Ebola projects | IMI Innovative Medicines Initiative Latest COVID-19 vaccine based on technology tested for safety & immunogenicity in IMI Ebola projects | IMI Innovative Medicines Initiative](https://www.imi.europa.eu/sites/default/files/styles/newsroom_details/public/uploads/images/news-events/Newsroom/j%20and%20j%20by%20rafapress%20via%20shutterstock.jpg?itok=gZGJMJG9)
Latest COVID-19 vaccine based on technology tested for safety & immunogenicity in IMI Ebola projects | IMI Innovative Medicines Initiative
![Johnson & Johnson 'Pauses' COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment - Health Policy Watch Johnson & Johnson 'Pauses' COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment - Health Policy Watch](https://i.ytimg.com/vi/tVdO5mzH1qU/maxresdefault.jpg)
Johnson & Johnson 'Pauses' COVID-19 Vaccine Trial Due To Unexplained Illness In Participant; Eli Lilly Reportedly Suspending Trial Of Antibody Treatment - Health Policy Watch
![Frontiers | The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies Frontiers | The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies](https://www.frontiersin.org/files/MyHome%20Article%20Library/560652/560652_Thumb_400.jpg)